HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Francois Rossignol Selected Research

nitazoxanide (NTZ)

4/2022Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence.
1/2020Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.
1/2020Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
7/2018Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57.
1/2018Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus.
1/2018The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication.
11/2017The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
8/2010Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.
8/2006Nitazoxanide for the treatment of Clostridium difficile colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Francois Rossignol Research Topics

Disease

7Infections
04/2022 - 11/2017
5Human Influenza (Influenza)
11/2020 - 11/2017
2Virus Diseases (Viral Diseases)
11/2020 - 01/2020
1COVID-19
04/2022
1Rotavirus Infections
10/2013
1Gastroenteritis
10/2013
1Hepatitis B
06/2011
1Chronic Hepatitis C
08/2010
1Colitis
08/2006

Drug/Important Bio-Agent (IBA)

9nitazoxanide (NTZ)FDA Link
04/2022 - 08/2006
5Antiviral Agents (Antivirals)IBA
04/2022 - 10/2013
3Oseltamivir (Tamiflu)FDA Link
11/2020 - 01/2020
2VaccinesIBA
04/2022 - 01/2018
1Zanamivir (Relenza)FDA Link
11/2020
1Neuraminidase (Sialidase)IBA
11/2020
1aminoxanideIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Pharmaceutical PreparationsIBA
01/2018
1Viral HemagglutininsIBA
01/2018
1Hemagglutinins (Hemagglutinin)IBA
11/2017
1tizoxanideIBA
11/2017
12- hydroxybenzoyl- N- (5- chlorothiazol- 2- yl)amideIBA
06/2011
1Ribavirin (Virazole)FDA LinkGeneric
08/2010
1Metronidazole (Metric)FDA LinkGeneric
08/2006

Therapy/Procedure

7Therapeutics
04/2022 - 08/2006
1Drug Therapy (Chemotherapy)
01/2018